Project Grant R34MH138136
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) provides $200,824 to The Miriam Hospital in Rhode Island to develop and pilot-test an AI-based chatbot intervention. The goal is to promote the use of doxycycline as post-exposure prophylaxis (Doxy-PEP) to prevent bacterial sexually transmitted infections, including syphilis, gonorrhea, and chlamydia, among men...
- This federal Project Grant award of $691,620.00 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will support the development of an online decision support approach leveraging social media to promote pre-exposure prophylaxis (PrEP) awareness and demand among women in the Southeastern United States. The key products and services to be delivered through this 3-year project include: Developing a replicable social media targeting...
- This Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop and pilot test a community health worker-delivered PrEP decision aid to facilitate PrEP initiation among Black women seeking HIV testing services in Eastern Virginia. The $179,731 award, with a project period from September 1, 2025 to August 31, 2030, will involve in-depth qualitative interviews to inform the adaptation of a PrEP...
- This $731,738 Project Grant awarded by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) will fund a pilot feasibility study to integrate pre-exposure prophylaxis (PrEP) into emergency department and urgent care settings using a patient-centered decision support tool. The goal is to improve PrEP awareness, access, and uptake among groups at highest risk for acquiring HIV, such as men who have sex with men, young people, racial/ethnic minorities, and women of...
- The National Institute of Mental Health (NIMH) awarded a $790,198 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Alabama at Birmingham (UAB) for the "PROTECT AL: PREP OPTIMIZATION THROUGH ENHANCED CONTINUUM TRACKING" project. The grant, awarded on September 18, 2025, aims to develop effective interventions to scale up and sustain HIV pre-exposure prophylaxis (PrEP) utilization in the Southern United States, a region disproportionately...
- This federal Project Grant award titled "STREAMLINING TELEHEALTH FOR EXPANDED PREP UTILIZATION THROUGH COMMUNITY PARTNERSHIPS (STEP-UP)" is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $744,279 award, effective from September 18, 2025 to September 17, 2028, supports the development and evaluation of an innovative model that positions community-based organizations (CBOs) as hubs for delivering pre-exposure...
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $193,754 to The Children's Hospital Corporation (dba Boston Children's Hospital) to develop an implementation strategy for pre-exposure prophylaxis (PrEP) in pediatric primary care settings. The key objectives are to: 1) explore barriers and facilitators to PrEP discussions, prescribing, and persistence among adolescents and young adults...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research on the influence of social networks on HIV testing and pre-exposure prophylaxis (PrEP) care among young Latin American gay, bisexual, and other men who have sex with men (GBMSM). The $485,131 award to the New York Blood Center, Inc. is focused on understanding how social capital, social bonding, and network stress within the local and...
- The National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), awarded a $191,117 project grant to The Regents of the University of California, San Francisco (UCSF) to develop and pilot an anti-stigma intervention aimed at improving personalized communication between pharmacy staff and individuals seeking pre-exposure prophylaxis (PrEP) for HIV prevention. The overarching goal is to adapt an existing effective anti-stigma intervention to the U.S....
- This Project Grant award, totaling $1,243,071.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant will fund the development of a new collaborative eligibility platform by Groupware Technologies, LLC (UEI: E8T9F94UU7D4) to support the application, determination, recertification, and enrollment processes for the Ryan White HIV/AIDS Program (RWHAP). The platform aims to increase linkage to care and retention...
This Project Grant award for $705,322.00, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop and test an AI-based chatbot intervention to promote HIV pre-exposure prophylaxis (PrEP) uptake among men who have sex with men (MSM) in Ending the HIV Epidemic (EHE) jurisdictions. The project, awarded to The Miriam Hospital, a division of Lifespan located in Rhode Island, will involve tailoring, refining, and piloting the AI-based chatbot called CHIA (Chatbot for HIV Prevention and Action) to employ motivational interviewing techniques. The goal is to assess HIV risk, determine individuals' readiness for change using the Transtheoretical Model, and provide stage-appropriate education and motivation to initiate PrEP. The award period runs from September 16, 2025 to September 15, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $705.3k | 9/16/25 |